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The effects of cold exposure and "14 administration  fructose 2,6-bisphosphate levels, phosphofructokinase-2 andpyru- 
vate kinase activities were examined in rat brown adipose tissue. Cold adaptation (14 days) gave rise to a 2-fold increase 
in the amount of fructose 2,6-bisphosphate and phosphofructokinase-2 activity, and increased the pyruvate kinase activ- 
ity 4-fold. If, in addition, the cold-acclimated rats were treated with I"4, these parameters were again significantly en- 
hanced. The effect on phosphofructokinase-2 was on the Vmax, without modification of the Km (for both fructose 6-phos- 
phate and ATP) of the enzyme. In the hypothyroid state, however, the activity of pyruvate kinase remains unchanged. 
These data support previous observations on stimulation of glycolytic flux during cold adaptation in brown adipose 
tissue, and a permissive role of thyroid hormones in the process. 
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1. INTRODUCTION 
Cold adaptation is closely related to an increase 
in the amount of brown adipose tissue (BAT) and 
mitochondria [1-3]. In addition to the role of fatty 
acid as the major fuel during cold exposure, recent 
studies have indicated that BAT plays an impor- 
tant role in regulating blood glucose concentration 
after a carbohydrate load, especially in cold- 
acclimated rats [4,5]. This is supported by the fact 
that the activities of hexokinase and 6-phospho- 
fructokinase (PFK-1) are increased in BAT during 
adaptation to low temperature [4]. A relationship 
between thermogenesis and thyroid hormones has 
been accepted [6], therefore it appeared to us of 
interest o relate the functional thyroid state to the 
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regulation of glucose metabolism during cold 
adaptation. 
Fructose 2,6-bisphosphate (Fru 2,6-P2) is a new- 
ly recognized, positive effector of PFK-1 in all ex- 
amined tissue [7] and its concentration is greatly 
increased under conditions in which glycolysis is 
active. Here, we investigate the effect of cold ex- 
posure and thyroid functional state on Fru 2,6-P2 
levels and the kinetic properties of PFK-2 in BAT. 
We report, for the first time, an increase in Fru 
2,6-P2 in cold-acclimated BAT and also under 
hyperthyroid conditions. PFK-2 and pyruvate 
kinase activities were also enhanced in these states. 
2. MATERIALS AND METHODS 
Male Wistar rats (170-200g) were used throughout. 
Hypothyroidism was induced as in [8]. Briefly, rats were made 
hypothyroid by treatment with NaC104 in the drinking water 
for 40 days and hyperthyroid with I"4 (1 mg/ml) added to the 
drinking water for 7 days. BAT was isolated from the in- 
terscapular depot and frozen in liquid N2. Fru 2,6-P2 was 
assayed as in [9]. The activity of PFK-2 was measured inpartial- 
ly purified preparations with polyethylene glycol as in [10]. For 
assay of pyruvate kinase activity, BAT and heart muscle (atrial 
and ventricular muscles, separately) were homogenized in 5 ml 
buffer containing 100 mM KC1 and 50 mM Gly-Gly, pH 7.4. 
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The homogenate was centrifuged at 15000 x g for 30 min. 
Small molecules were eliminated by passing the supernatant 
through a Sephadex G-25 (fine) column. An aliquot of the 
eluted fluid was used to determine the pyruvate kinase activity 
as in [11]. Lactic dehydrogenase ctivity was assayed as in [12]. 
All biochemical nd purified enzymes were obtained from 
Sigma and Boehringer. Fructose 2,6-P2 standard was kindly 
donated by E.V. Schaftingen and H.G. Hers (Lahoratoire de 
Chimie Physiologique, Universit6 Catholique de Louvain, 
Belgium). 
3. RESULTS AND DISCUSSION 
3.1. Effect of  cold adaptation in brown adipose 
tissue 
The levels of Fru 2,6-P2 and activities of PFK-2 
and pyruvate kinase in BAT are listed in table 1. 
Maintenance of rats at 4°C for 13 days doubled the 
concentration of Fru 2,6-P2 and the PFK-2 activi- 
ty. Since Fru 2,6-P2 is the major factor responsible 
for the regulation of glycolysis, the increased levels 
of  this metabolite during cold acclimatization sug- 
gest that the overall glycolysis flux is stimulated at 
the level of the PFK-1 step. This assumption is 
reinforced by the fact that pyruvate kinase activity 
was also enhanced (table 1). An increase of hex- 
okinase and PFK-1 has also been reported [4]. The 
increased content of Fru 2,6-P2 could also enhance 
the rate of the Fru 6-P/Fru 1,6-P2 cycle during 
cold adaptation, in  order to generate heat as is 
known to occur in muscle [13]. The amount of Fru 
2,6-P2 in this tissue (0.32 pmol/g wet tissue) is of 
the same order as that previously found in white 
adipose tissue [9]. The increased activities of the 
cited enzymes provide new data to explain the 
enhanced capacity for oxidizing glucose during 
cold adaptation, and suggest hat in this state the 
synthesis of enzymatic proteins is stimulated. 
Table 1 also shows the effect of T4 on the studied 
parameters. It is shown that in BAT the hyper- 
thyroid state was associated with a clear stimula- 
tion of PFK-2 and pyruvate kinase activities and 
an increase in the tissue levels of Fru 2,6-P2. These 
data may be of interest in the light of the increased 
rate of energy consumption and stimulation of ox- 
idative metabolism after the addition of T4 [15,16], 
events associated with a greater requirement of 
substrate. 
3.2. Kinetic parameters of PFK-2 from brown 
adipose tissue 
Because the adaptation to cold produces an in- 
Table 1 
Effect of cold exposure and T4 treatment on Fru 2,6-P2 levels, 
and activities of PFK-2 and pyruvate kinase in brown adipose 
tissue 
Fru 2,6-P2 PFK-2 Pyruvate 
(nmol/g ~U/unit kinase 
tissue) LDH) (U/unit LDH) 
Normal (6) 0.327 +_ 0.05 1.37 ± 0.05 7.00 ± 1.0 
Cold-acclimated 
(8) 0.739 +_ 0.05 2.86 ± 0.16 29.49 ± 1.2 
Cold-acclimated + 
T4 treatment 
(5) 1.320 ± 0.12 4.08 + 0.18 43.97 _+ 2.2 
Brown adipose tissue was homogenized and treated as indicated 
in section 2. Values are means ± SE. The number of rats is 
indicated in parentheses 
crease in both maximal activity of PFK-2 and Fru 
2,6-P2 concentration, it is of interest to study 
whether other kinetic properties of the enzyme 
were modified in this state. Fig.l shows the 
dependence of PFK-2 activity on Fru 6-P concen- 
tration. The effect of adaptation to cold was on the 
Vmax of the enzyme, while the Km remained un- 
changed regarding control conditions. Similar 
results were found when the effect of ATP, 
another substrate for the enzyme, was studied (not 
shown). Since the enzyme activity was measured 
after precipitation with polyethylene glycol, the 
observed effect was not due to the presence of (a) 
putative effector(s) present in the homogenate. 
Recently, the existence of isoenzymes of PFK-2 has 
been postulated [17]. Fig. 1B illustrates that PFK-2 
activity from brown adipose tissue is progressively 
inhibited by citrate, whereas glycerol 3-P shows 
scarcely any capacity for inhibition of the enzyme 
activity. These properties resemble those of the 
cardiac isoenzyme of PFK-2 [17]. 
3.3. Pyruvate kinase activity in BAT and heart 
It is accepted that thyroid hormones induce the 
stimulation of glucose utilization in muscle and in 
adipose tissue [14]. In heart muscle, hypo- 
thyroidism produces a decrease in Fru 2,6-P2 levels 
and PFK-1 activity, whereas the hyperthyroid state 
is without effect [8]. Table 2 shows the activity of 
pyruvate kinase under these conditions. In BAT, 
hypothyroidism was without effect, whereas the 
augmentation of T4, enhanced the activity of 
pyruvate kinase. This last result agrees with the in- 
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Fig. 1. Affinity of PFK-2 for Fru 6-P (A) and effect of glycerol 3-P and citrate on the activity of PFK-2 (B) from brown adipose tissue. 
The enzyme was partially purified from normal (O) and cold-acclimated rats (O, D, A). Fru 6-P and ATP concentrations in (B) were 
0.1 and 0.5 raM, respectively. 
crease observed in the pyruvate kinase activity in 
cold-adapted rats (table 1). A different situation 
appears in heart muscle where neither 
hypothyroidism nor hyperthyroidism alters the ac- 
tivity of the enzyme. Recently, regional differences 
in the insulin regulation of atrial and ventricular 
PFK-1 activity have been shown [19]. The 
possibility that thyroid hormones also regulate the 
cardiac pyruvate kinase in a regional manner has 
been evaluated. However, the available data in- 
dicate that the kinetic parameters of the enzyme 
were unchanged by the thyroid state in either atrial 
or ventricular muscle (atrial muscle: Km= 
0.05 raM, Vm~, = 0.4 U/mg protein; ventricular 
muscle: Km = 0.06mM, Vm~ = 0.5U/mg 
protein). 
3.4. General conclusions 
This study demonstrates that cold exposure and 
T4 administration in viva can increase several-fold 
the enzyme activities associated with the glycolytic 
pathway in BAT. These changes could be part of 
a co-ordinated response of glucose catabolism in 
response to cold, since thermogenesis requires a 
continuous source of oxidizable substrates. On the 
basis of the results presented above, it can be con- 
Table 2 
Effect of thyroid state on pyruvate kinase activity in brown 
adipose tissue and heart muscle 
State Pyruvate kinase activity 
(mU/mg protein) 
BAT Heart 
Normal (6) 64.6 + 3.4 650 ± 15 
Hypothyroid (7) 73.9 + 2.5 600 -e 11 
Hyperthyroid (7) 160.7 + 5.8 a 634 + 12 
Rat brown adipose tissue and heart muscle, in several thyroid 
states, were homogenized and filtered on Sephadex G-25. 
Pyruvate kinase activity was assayedJn_the eluted fractions. The 
number of rats used is given in parentheses, a p < 0.001 vs 
normal rats 
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c luded that the relative importance of  Fru 2,6-P2 as 
a regulator  of  glycolysis is increased during cold 
exposure and hyperthyro id ism in BAT.  Recently it 
has been shown that thyro idectomized rats are 
unable to survive chronic exposure to cold [20]. In 
addit ion,  the act ion of  thyro id  hormones in the 
st imulat ion of  thermogenesis well documented 
(review [6]). Our  results about  the permissive role 
o f  T4 treatment in PFK-2 and pyruvate kinase ac- 
tivities in BAT support  this suggestion. The dif- 
ferent responses among tissues to thyro id  
hormones  are also noteworthy.  Thus, cardiac 
pyruvate kinase does not show the thyro id adap-  
t ivity that is seen in BAT during hyperthyroid ism. 
Further  work should be directed toward  
establ ishing flux rates for glucose oxidat ion in 
BAT,  and in making further compar isons in nor-  
mal  and pathophysio logical  states. 
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